Tilray and AB InBev Launch Canadian Research Partnership

December 20, 2018

New York - Paul Hastings, a leading global law firm, announced today that the firm represented Tilray, Inc., a global pioneer in cannabis production and distribution on the formation of a research partnership with AB InBev, the world’s leading brewer. The partnership is focused on research for non-alcoholic beverages containing tetrahydrocannabinol (THC) and cannabidiol (CBD), and is limited to Canada.

Tilray’s participation in the partnership will be through its Canadian adult-use cannabis subsidiary, High Park Company, and AB InBev will participate via Labatt Breweries of Canada. Each intends to invest up to $50 million in the partnership, for a total of up to $100 million.

The Paul Hastings team was led by partner Barry Brooks, and also included associate Asna Shah.

At Paul Hastings, our purpose is clear—to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.